R3 Bio operated in secrecy for years before revealing last week that it had raised money to create nonsentient monkey "organ sacks" (Technology Review, March 30 2026, https://www.technologyreview.com/2026/03/30/1134836/the-download-brainless-human-clones-first-uterus-kept-alive-outside-body/). The newsletter edition is titled "The Download: brainless human clones and the first uterus kept alive outside a body" and describes the startup's pitch for brainless human clones (Technology Review, March 30 2026).

The report states R3 Bio is a California-based startup that suddenly revealed its activities after stealth operations (Technology Review, March 30 2026). Primary source details remain confined to the funding announcement and description of nonsentient monkey organ sacks with no additional technical specifications provided (Technology Review, March 30 2026).

The same newsletter covers the first uterus kept alive outside a body as a separate development in ex vivo organ maintenance, citing no further primary sources or external references (Technology Review, March 30 2026). All facts derive directly from the provided MIT Technology Review edition without extrapolation.